Thirty Madison to Combine With Nurx to Create One Virtual Specialty Care Platform

New York – February 11, 2022 – Cooley advised Thirty Madison, a specialty healthcare company for people living with chronic conditions, on its agreement to merge with women-focused digital healthcare company Nurx. Partners Ian Nussbaum and Adam Dinow led the Cooley team advising Nurx. 

The partnership, which will be under the Thirty Madison brand, will allow users greater access to care on a single, unified platform, rapidly accelerate the use of Thirty Madison’s specialist-level care model through a breadth of new condition offerings, and grant access to a broader reach of patients through employers and payers by innovative partnerships.

“What the Nurx team has built for its patients is remarkable, and is exactly what brought our two companies together: a relentless focus on our patients’ many different needs through personalized treatment and expert care,” Steve Gutentag, co-founder and CEO of Thirty Madison, said in a news release. “This partnership accelerates our ability to serve patients at an even greater scale by immediately doubling the number of conditions we cover and the number of patients on our platform.” 

Founded in 2017, Thirty Madison helps patients manage chronic medical conditions requiring varying needs of specialty care, from low acuity to high acuity, through its integrated care model. Thirty Madison’s unique care model delivers accessible, affordable care and superior outcomes for hundreds of thousands of patients. This specialized care model is powered by the company’s proprietary platform that delivers the technology, services and physical infrastructure needed to provide high-quality care to an increasing number of patients.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. 

Cooley has 1,500 lawyers across 17 offices in the United States, Asia and Europe.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.